Literature DB >> 20722776

Penile sclerosing lipogranulomas and disfigurement from use of "1Super Extenze" among Laotian immigrants.

Ted Manny1, Joseph Pettus, Ashok Hemal, Malcolm Marks, Majid Mirzazadeh.   

Abstract

INTRODUCTION: Subcutaneous penile injection of various oils for penile augmentation has been described among men in Laos. We have now treated three Laotian immigrants with penile disfigurement secondary to sclerosing lipogranulomas, also known as paraffinoma, induced by injection of a mineral oil compound marketed as "1Super Extenze," which they purchased in the United States. AIM: This series describes the clinical course and management of complications associated with the use of "1Super Extenze" in three Laotian men.
METHODS: Surgeons excised all grossly affected tissue and performed reconstruction using skin grafting, Z-plasty, and tissue advancement, respectively. Tissue from the penile shaft of each patient and a local lymph node in one patient was examined microscopically. Mass spectroscopy was performed on an aliquot of "1Super Extenze." MAIN OUTCOME MEASURES: Urinary function, sexual function, and cosmesis of the three reported cases, chemical composition of "1Super Extenze," and microscopic analysis of penile and regional lymphatic tissue.
RESULTS: Short-term cosmetic and functional outcomes were acceptable after surgical intervention. Histologic findings consistent with sclerosing lipogranulomas were seen in specimens from affected subcutaneous and lymphatic tissue. "1Super Extenze" proved to be composed of mineral oil with tocopherol acetate (vitamin E).
CONCLUSION: Injection of "1Super Extenze" into the penile shaft results in sclerosing lipogranulomas, which can cause severe sexual and urinary complications. Surgical resection of all grossly involved tissue with appropriate reconstruction can mitigate these problems. This series supports previous recommendations in the literature that men should avoid the use of non-medical foreign bodies and fillers as means of penile augmentation.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722776     DOI: 10.1111/j.1743-6109.2010.01980.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  7 in total

1.  Impact of penile size on male sexual function and role of penile augmentation surgery.

Authors:  Osama Shaeer; Kamal Shaeer
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

2.  A new surgical method for penile girth enhancement.

Authors:  Xiaoge Li; Ling Tao; Chuan Cao; Haishan Shi; Le Li; Liang Chen; Shirong Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Subcutaneous penile insertion of domino fragments by incarcerated males in southwest United States prisons: a report of three cases.

Authors:  Steven J Hudak; James McGeady; Alan W Shindel; Benjamin N Breyer
Journal:  J Sex Med       Date:  2011-11-14       Impact factor: 3.802

Review 4.  Autoimmune/inflammatory syndrome induced by mineral oil: a health problem.

Authors:  Olga Vera-Lastra; Gabriela Medina; María Pilar Cruz-Domínguez; Gabriel Medrano Ramírez; Raymundo Benjamin Priego Blancas; Ana Lilia Peralta Amaro; Anabel Villanueva Martínez; Jesús Sepúlveda Delgado; Luis J Jara
Journal:  Clin Rheumatol       Date:  2018-04-04       Impact factor: 2.980

Review 5.  Sclerosing lipogranuloma of the penis: a narrative review of complications and treatment.

Authors:  Boyke Soebhali; João Felicio; Pedro Oliveira; Francisco E Martins
Journal:  Transl Androl Urol       Date:  2021-06

Review 6.  Obstructive lower urinary tract symptoms (LUTS) as the initial presentation of penile paraffinoma: a case report and literature review.

Authors:  Asterios Symeonidis; Evangelos N Symeonidis; Chrysovalantis Toutziaris; Georgios Dimitriadis
Journal:  Pan Afr Med J       Date:  2021-03-15

7.  Penile skin preservation technique for reconstruction surgery of penile paraffinoma.

Authors:  Jong Sung Kim; Yu Seob Shin; Jong Kwan Park
Journal:  Investig Clin Urol       Date:  2019-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.